RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors
RICTOR 扩增定义了一组可能受益于 mTORC1/2 抑制剂治疗的肺癌患者新亚群
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-14-0971
Haiying Cheng, Yiyu Zou, Jeffrey S Ross, Kai Wang, Xuewen Liu, Balazs Halmos, Siraj M Ali, Huijie Liu, Amit Verma, Cristina Montagna, Abraham Chachoua, Sanjay Goel, Edward L Schwartz, Changcheng Zhu, Jidong Shan, Yiting Yu, Kira Gritsman, Roman Yelensky, Doron Lipson, Geoff Otto, Matthew Hawryluk, P
